GLP-1 TikTok trends: separating hype from clinical evidence

What's this video probably claiming?

Based on the caption referencing a discount code and GLP-1 framing, this video is almost certainly promoting access to a GLP-1 receptor agonist, likely a compounded semaglutide or tirzepatide product, through an affiliate or referral arrangement. Creators in this space typically walk through personal weight loss results, quote weekly doses, and position compounded versions as a budget-friendly alternative to brand-name drugs like Ozempic or Wegovy. The discount code structure suggests a partnership with a telehealth or compounding pharmacy. These videos often include before/after framing, appetite suppression anecdotes, and claims about how quickly results show up. What they rarely include: any mention of the FDA's ongoing concerns about compounded GLP-1 products, the difference in quality standards between 503A and 503B compounding facilities, or the fact that individual response to these drugs varies enormously based on dose titration, baseline metabolic health, and adherence to lifestyle changes.

What does the science actually show?

The clinical evidence for GLP-1 receptor agonists in weight management is genuinely strong, which is part of why these videos get so much traction. The STEP 1 trial (Wilding et al., 2021, NEJM) showed semaglutide 2.4mg weekly produced mean body weight reduction of 14.9% over 68 weeks in adults with obesity. Tirzepatide performed even better in the SURMOUNT-1 trial (Jastreboff et al., 2022, NEJM), with the 15mg dose achieving 20.9% mean weight loss over 72 weeks. These are meaningful numbers from large, randomized, placebo-controlled trials. But the social media version of these results tends to skip a few things: participants also received lifestyle intervention support, dropout rates due to GI side effects were non-trivial, and weight regain after discontinuation was documented in the STEP 4 extension trial at roughly 6.9% body weight within one year of stopping. The drug works while you take it. That context rarely makes it into a 60-second clip with a promo code.

Where does the social media noise diverge from clinical reality?

The biggest gap between TikTok GLP-1 content and clinical reality is the compounding question. The FDA placed semaglutide and tirzepatide on its drug shortage list, which temporarily opened a legal window for compounding pharmacies to produce copies. That window has been contested and is narrowing. The FDA does not evaluate compounded drugs for safety, efficacy, or manufacturing quality the way it does approved products. A 2023 FDA advisory specifically flagged reports of dosing errors with compounded semaglutide, some involving products labeled in units rather than milligrams, leading to tenfold dosing mistakes. Beyond compounding, social media creators frequently attribute all weight loss to the drug while underplaying caloric deficit, protein intake, and resistance training, factors that researchers like Hall et al. (2022, Obesity) argue significantly modify outcomes. The drug is a tool. It is not, by itself, a complete metabolic intervention.

What should you actually know?

If you are considering a GLP-1 medication, a few things are worth knowing before a discount code influences your decision. First, GLP-1 agonists are prescription medications with real contraindications, including personal or family history of medullary thyroid carcinoma and multiple endocrine neoplasia type 2. Second, common side effects including nausea, vomiting, and constipation affect a substantial portion of users, with the STEP trials reporting GI adverse events in over 70% of the semaglutide group. Third, compounded versions are not FDA-approved and should not be treated as equivalent to brand-name products regardless of what a creator implies. Fourth, long-term data beyond 3 years remains limited. The SELECT trial (Lincoff et al., 2023, NEJM) showed cardiovascular benefit with semaglutide 2.4mg, which is meaningful, but this was in a specific high-risk population. Talk to a licensed prescriber who reviews your full history, not a TikTok discount code, before starting.